- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on NSCLC in Canada
Total 85 results
-
Spanish Lung Cancer GroupCompleted
-
Lady Davis InstituteWithdrawn
-
Exactis InnovationRecruiting
-
Fundación GECPActive, not recruitingNSCLC | Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIBSpain
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
University of AlbertaJohnson & JohnsonCompletedOperable Early Stage NSCLC by the VATS ApproachCanada
-
Hamilton Health Sciences CorporationUnknown
-
AstraZenecaCompletedNSCLCSweden, Bulgaria, Mexico, Russian Federation, Turkey, United Kingdom, Philippines, Malaysia, Germany, Hungary, Latvia, Lithuania, Poland, Romania, Netherlands, Norway, Argentina, Australia, Canada, Slovakia, Greece, Taiwan, Thailand, ... and more
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
St. Joseph's Healthcare HamiltonCompletedNSCLC | Lung Cancer | Artificial Intelligence | Elastography | Endobronchial UltrasoundCanada
-
Alethia BiotherapeuticsCompletedNSCLC Stage IVUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingNSCLC | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | TNBC - Triple-Negative Breast Cancer | NSCLC Stage IV Without EGFR/ALK MutationUnited States, Canada
-
Stanford UniversityCompletedNon-small Cell Lung Cancer (NSCLC)United States, Japan, Canada
-
University Health Network, TorontoCompletedNon Small Cell Lung Cancer (NSCLC)Canada
-
Novartis PharmaceuticalsRecruitingAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MelanomaNetherlands, Korea, Republic of, Spain, Taiwan, Japan, Italy, United States, Singapore, Canada
-
iTeos Belgium SARecruitingMetastatic NSCLC | Stage III NSCLCUnited States, Belgium, Spain, Switzerland, Italy, France, Canada, Poland, Czechia
-
Monte Rosa Therapeutics, IncRecruitingNSCLC | Prostate Cancer | SCLC | DLBCL | High Grade Neuroendocrine Cancer | L-MYC and N-MYC Amplified Solid Tumors | NSCLC With High or Low L-MYC or N-MYC Expression | HR-positive, HER2-negative Breast CancerUnited States, Canada
-
University Health Network, TorontoUniversity of AmsterdamRecruitingMelanoma | Kidney Cancer | Head and Neck Cancer | NSCLC | Urothelial CarcinomaCanada
-
Novartis PharmaceuticalsTerminatedMelanoma | Ovarian Cancer | NSCLC | Other Solid TumorsItaly, Spain, Netherlands, France, Korea, Republic of, Switzerland, Germany, Japan, United States, Canada
-
Canadian Cancer Trials GroupNovartisRecruiting
-
Hoffmann-La RocheCompletedNon-Small Cell Lung Cancer (NSCLC)Spain
-
AmgenActive, not recruitingKRAS p, G12c Mutated /Advanced Metastatic NSCLCFinland, United States, Canada, Belgium, Spain, Korea, Republic of, Netherlands, United Kingdom, Australia, Denmark, Hungary, Sweden, Taiwan, Greece, Russian Federation, Switzerland, France, Italy, Japan, Poland, Brazil, Germany, Po...
-
AstraZenecaCompletedRefractory Solid Tumours | Relapsed Small Cell Lung Cancer (SCLC)United States, Canada
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedChronic Obstructive Pulmonary Disease (COPD) | Non-small Cell Lung Cancer (NSCLC)United States, Canada
-
Centre hospitalier de l'Université de Montréal...RecruitingAdvanced Non-Small Cell Lung Cancer | Unresectable Melanoma | NSCLC Stage IV | Melanoma Stage IVCanada
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
AstraZenecaCompletedNSCLCAustralia, United Kingdom, Canada, Netherlands, Czech Republic
-
AstraZenecaQuintiles, Inc.CompletedNSCLCBulgaria, France, Italy, Mexico, Peru, Russian Federation, Spain, Turkey, United Kingdom, Sweden, Poland, Ukraine, Chile, Hungary, Israel, Netherlands, Portugal, Romania, Germany, Austria, Belgium, Canada, Australia
-
MedImmune LLCCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC) | Small Cell Lung Cancer (SCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Head and Neck Squamous Cell Carcinoma (HNSCC) | Colorectal Cancer (CRC) | Non Small Cell Lung Cancer Squamous (NSCLC-Sq)United States, Canada
-
CTI BioPharmaTerminatedNSCLCUnited States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Concordia Laboratories Inc.CompletedNon-small Cell Lung Cancer (NSCLC) | Lung MetastasisUnited States, Canada
-
BayerCompletedHepatocellular Carcinoma (HCC) | Non-small Cell Lung Cancer (NSCLC) | Head and Neck Squamous Cell Carcinoma (HNSCC)United States, Canada
-
Spectrum Pharmaceuticals, IncTerminatedNSCLCUnited States, Canada, Netherlands, Belgium, Israel, Spain, France, Italy
-
MedImmune LLCCompletedNSCLC | Resectable | Early-stageUnited States, Canada, Switzerland, Italy, France, Portugal, Spain
-
University of ColognePfizer; Spanish Lung Cancer GroupCompletedAdenocarcinoma | NSCLC | Lung CancerGermany, Spain, Switzerland
-
AstraZenecaParexelRecruitingNon-Small Cell Lung Cancer (NSCLC)Korea, Republic of, Malaysia, Taiwan, Thailand, Hong Kong, Singapore, Canada
-
Elevation OncologyMerrimack PharmaceuticalsTerminatedAdenocarcinoma | Non-Small Cell Lung Cancer | NSCLC | HeregulinSpain, Canada, United States, Germany, Hungary, France
-
Hoffmann-La RocheActive, not recruitingNSCLCBelgium, Australia, China, Croatia, Finland, Turkey, Italy, Israel, Serbia, Austria, Romania, Peru, Lithuania, Colombia, Portugal, Czechia, Cuba, Russian Federation, Bulgaria, Vietnam, Uruguay, United Arab Emirates, Argentina, Chile, Pa...
-
Genentech, Inc.RecruitingMelanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCCKorea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedNon-Small Cell Lung Cancer (NSCLC)United States, Canada, France, Singapore, Taiwan
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
AstraZenecaRecruitingNSCLCChina, United States, United Kingdom, Korea, Republic of, Italy, Hungary, Spain, Vietnam, France, Brazil, Canada, Japan, Taiwan, Germany, Austria, Turkey, India, Peru, Poland, Sweden, Bulgaria, Greece, Mexico, Denmark
-
NovaceaUnknownNon Small Cell Lung Cancer (NSCLC) | Androgen Independent Prostate Cancer (AIPC)Canada, United States
-
ETOP IBCSG Partners FoundationRoche Pharma AGActive, not recruitingEGFRmutant Stage IIIB/C or IV Non-squamous NSCLCSingapore, Spain, Korea, Republic of, Switzerland, Germany
-
Fundación GECPCompletedSmall Cell Lung Cancer (SCLC)Spain
-
TakedaCompletedNon-small Cell Lung Cancer (NSCLC)Hong Kong, France, Canada
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
CSL BehringCompletedFatigue | NSCLC | CachexiaCanada, Australia, Russian Federation, Georgia, Serbia, India, New Zealand, Poland, Romania